Education
About Us
Working with TipRanks
Follow Us
Matthias Bodenstedt Insider Profile
4 Followers
Matthias Bodenstedt, CFO at MoonLake Immunotherapeutics, holds 627.54K shares in MoonLake Immunotherapeutics (Ticker: MLTX). Most recently, Matthias Bodenstedt Bought 10,870 shares of MoonLake Immunotherapeutics on Oct 09, 2025 for an estimated value of $98.81K.
Matthias Bodenstedt has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Matthias Bodenstedt's holdings
Insider Roles
CFO
Roles that Matthias Bodenstedt holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Oct 09, 2025 - Today
Return:-2.70%
The most profitable trade made by Matthias Bodenstedt
Matthias Bodenstedt's Trading History
List of latest transactions for each holding click on a transaction to see Matthias Bodenstedt's performance on stock
You May Also Like
Matthias Bodenstedt insider profile FAQ
What is the percentage of profitable transactions made by Matthias Bodenstedt?
The percentage of profitable transactions made by Matthias Bodenstedt is ―.
What is the average return per transaction made by Matthias Bodenstedt?
The average return per transaction made by Matthias Bodenstedt is ―.
What stocks does Matthias Bodenstedt hold?
Matthias Bodenstedt holds: MLTX stocks.
What was Matthias Bodenstedt’s latest transaction?
Matthias Bodenstedt latest transaction was an Informative Buy of $98.81K.
What was Matthias Bodenstedt's most profitable transaction?
Matthias Bodenstedt’s most profitable transaction was an Informative Buy of MLTX stock on October 9, 2025. The return on the trade was -2.70%.
What is Matthias Bodenstedt's role in MoonLake Immunotherapeutics?
Matthias Bodenstedt's role in MoonLake Immunotherapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.